Taxon Biosciences Inc

KineMed Inc. is a leading biotech company based in Emeryville, CA, dedicated to accelerating drug development by collaborating with major pharmaceutical and biotechnology firms. Founded by inventor Marc Hellerstein in 2001, the company focuses on pathway-based drug discovery and development, offering data on target engagement, toxicity, and disease progression to optimize the process and reduce associated risks. Specializing in real-time insights into conditions such as metabolic disorders, cancer, and neurodegenerative diseases, KineMed enables the identification of active drug candidates preclinically and confirms their therapeutic efficacy. The company has played a significant role in expediting the drug development process, underscoring its commitment to innovation in medical diagnostics and therapeutics. Generated from the website

Biotime, also known as Embryome Sciences, is a leading biotech company based in Alameda, CA, specializing in stem cell technology and blood plasma volume expanders for the medical industry. With over 200 patented biotech designs, the company's team of scientists at their office in the Harbor Bay Business Park area on Bay Farm Island is dedicated to advancing regenerative medicine and cutting-edge technologies. Generated from their available business information

Cureline is a global translational and precision medicine Contract Research Organization (CRO) based in South San Francisco, California. Since its establishment in 2003, Cureline has been providing comprehensive biobanking and laboratory services for accelerated drug research and development (R&D) and diagnostic (Dx) development. With a collaborative approach to project management, Cureline offers standard and custom protocols and services, precision medicine expertise in major therapeutic areas, and a global clinical network and regulatory expertise. As a trusted partner in HBS validation studies, Cureline specializes in the procurement of high-quality human biospecimens, including fresh human tissue, blood, biofluids, and frozen hematology cells. They also offer validated HBS sets for biomarker development, immuno-oncology HBS ready for functional assays, normal control HBS from healthy donors, and analytical services for histology and molecular analysis. With over 150 validated clinical partners in 20 countries, Cureline has a strong track record of completing projects for satisfied clients and has participated in major scientific consortiums such as the TCGA and the CPTAC.Generated from the website